Laboratory research materials for in vitro use only.

Tesamorelin

For laboratory research use only (in vitro). Not for human or animal use.

Price range: $35.99 through $153.99

BACKORDER — 25% Off

This item is currently out of stock and available on backorder. There is no guaranteed delivery timeline — shipping could take 6+ weeks depending on supplier availability and international logistics.

Volume Pricing

QuantityDiscountUnit Price
1-2 unitsStandard$109.99
3-4 units5% off$104.49
5-9 units10% off$98.99
10+ units Best Value15% off$93.49

Why researchers choose PBC:

  • HPLC-verified purity on every lot
  • Certificate of Analysis included
  • Temperature-controlled shipping
  • Canadian lab — documented supply chain
  • Batch-level traceability

Accepted payment methods:

InteracVisaMCCrypto

Certificate of Analysis available upon request. Contact us for lot-specific documentation.

Product Specifications

Amino Acid Sequence (Trans-3-hexenoic acid)-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
Molecular Weight 5135.9 Da
Molecular Formula C221H366N72O67S1
CAS Number 218949-48-5
Purity ≥98% (HPLC)
Format Lyophilized Powder
Vials Per Kit 10
Storage Store at -20C. Reconstituted: 2-8C
Research Status Approved

For laboratory research use only (in vitro). Not for human or animal use.

Description

Chemical Identity

Tesamorelin analytical reference compound. Molecular weight 5135.9 Da.

Specifications

Sequence (Trans-3-hexenoic acid)-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
Molecular Weight 5135.9 Da
Molecular Formula C221H366N72O67S1
CAS 218949-48-5
Purity >=98% (HPLC)
Format Lyophilized powder
Storage Store at -20C. Reconstituted: 2-8C

For laboratory research use only (in vitro). Not for human or animal use.

Additional information

Size

2mg, 5mg, 10mg

Published Research

4 references

References are provided for informational purposes to support in vitro laboratory research. No claims are made regarding therapeutic applications.

Effects of tesamorelin on visceral fat and metabolic parameters in HIV-infected patients with abdominal fat accumulation (Pivotal Trial 1)

Falutz J, Allas S, Blot K, et al. (2007). New England Journal of Medicine. PubMed 18057338

Tesamorelin for the treatment of trunk fat in HIV-infected patients (Pivotal Trial 2)

Falutz J, Potvin D, Mamputu JC, et al. (2010). Journal of Acquired Immune Deficiency Syndromes. PubMed 20101189

Tesamorelin reduces liver fat and hepatic steatosis in HIV-associated NAFLD (GILT Trial)

Stanley TL, Fourman LT, Feldpausch MN, et al. (2019). Lancet HIV. PubMed 31611038

Tesamorelin and cognitive function in healthy older adults

Baker LD, Barsness SM, Borber S, et al. (2012). Archives of Neurology. PubMed 22869065

For laboratory research use only (in vitro). Not for human or animal use.

Age Verification Required

You must be 19 years of age or older to access this website. This site contains laboratory research materials restricted to qualified personnel.